PubMed

Terminal ballistics of kinase inhibitors: there are no magic bullets.

Maitland ML, Ratain MJ.

Ann Intern Med. 2006 Nov 7;145(9):702-3. No abstract available. PMID: 17088586 [PubMed - indexed for MEDLINE]Related articlesFree article

Can acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors be overcome by different small-molecule tyrosine kinase inhibitors?

Bunn PA Jr.

J Clin Oncol. 2007 Jun 20;25(18):2504-5. No abstract available. PMID: 17577025 [PubMed - indexed for MEDLINE]Related articles

[Tyrosine kinase inhibitors]

Yagasaki F.

Nippon Naika Gakkai Zasshi. 2007 Jul 10;96(7):1411-9. Review. Japanese. No abstract available. PMID: 17682429 [PubMed - indexed for MEDLINE]Related articles

Tyrosine kinase inhibitors: who will benefit?

Bradbury J.

Lancet Oncol. 2007 Jul;8(7):579. No abstract available. PMID: 17668487 [PubMed - indexed for MEDLINE]Related articles

Small molecule inhibitors of tyrosine kinase: waiting for the good news in colorectal cancer as well.

Sobrero A, Andretta V.

Onkologie. 2008 May;31(5):224-5. Epub 2008 Apr 10. No abstract available. PMID: 18497509 [PubMed - indexed for MEDLINE]Related articles

Targeting cancers with tyrosine kinase inhibitors: lessons learned from chronic myeloid leukaemia.

Mughal TI, Goldman JM.

Clin Med. 2006 Nov-Dec;6(6):526-8. No abstract available. PMID: 17228548 [PubMed - indexed for MEDLINE]Related articles

Transient sunitinib-induced coma in a patient with fibromyxoid sarcoma.

Arnaud L, Schartz NE, Bousquet G, Sarandi F, Verola O, Madelaine I, Kerob D, Lebbe C.

J Clin Oncol. 2008 Mar 20;26(9):1569-71. No abstract available. Erratum in: J Clin Oncol. 2008 May 20;26(15):2604. PMID: 18349416 [PubMed - indexed for MEDLINE]Related articles

Reader seeks clarification on hand-foot skin reaction.

Clark M.

Clin J Oncol Nurs. 2008 Jun;12(3):395; author reply 395. No abstract available. PMID: 18564457 [PubMed - indexed for MEDLINE]Related articles

Multitarget tyrosine kinase inhibition: [and the winner is...].

Verweij J, de Jonge M.

J Clin Oncol. 2007 Jun 10;25(17):2340-2. Review. No abstract available. PMID: 17557945 [PubMed - indexed for MEDLINE]Related articles

Acquired resistance to tyrosine kinase inhibitors during cancer therapy.

Engelman JA, Settleman J.

Curr Opin Genet Dev. 2008 Feb;18(1):73-9. Epub 2008 Mar 5. Review.PMID: 18325754 [PubMed - indexed for MEDLINE]Related articles

Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib.

Chorianopoulos E, Jäger D, Katus HA, Frey N.

Clin Res Cardiol. 2007 Nov;96(11):829-30. Epub 2007 Aug 21. No abstract available. PMID: 17694380 [PubMed - indexed for MEDLINE]Related articles

Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.

Wu J, Meng F, Kong LY, Peng Z, Ying Y, Bornmann WG, Darnay BG, Lamothe B, Sun H, Talpaz M, Donato NJ.

J Natl Cancer Inst. 2008 Jul 2;100(13):926-39. Epub 2008 Jun 24.PMID: 18577747 [PubMed - indexed for MEDLINE]Related articlesFree article

[Management of chronic myeloid leukemia]

Kubuki Y.

Rinsho Ketsueki. 2008 Oct;49(10):1401-10. Review. Japanese. No abstract available. PMID: 18833925 [PubMed - indexed for MEDLINE]Related articles

[Kinase inhibitors]

Hagiwara M, Usuki H.

Tanpakushitsu Kakusan Koso. 2007 Oct;52(13 Suppl):1708-12. Review. Japanese. No abstract available. PMID: 18051404 [PubMed - indexed for MEDLINE]Related articles

Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.

Khan KA, Junaid A, Siddiqui NS, Mukhtar K, Siddiqui S.

J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.PMID: 18460249 [PubMed - indexed for MEDLINE]Related articles

[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors]

Deslandres M, Sibaud V, Chevreau C, Delord JP.

Ann Dermatol Venereol. 2008 Jan;Spec No 1:16-24. Review. French. PMID: 18342113 [PubMed - indexed for MEDLINE]Related articles

Cardiac toxicity of sunitinib.

Joensuu H.

Lancet. 2007 Dec 15;370(9604):1978-80. No abstract available. PMID: 18083385 [PubMed - indexed for MEDLINE]Related articles

Bullous sweet syndrome in a patient with t(9;22)(q34;q11)-positive chronic myeloid leukemia treated with the tyrosine kinase inhibitor nilotinib: interphase cytogenetic detection of BCR-ABL- positive lesional cells.

Kaune KM, Baumgart M, Gesk S, Mitteldorf C, Baesecke J, Glass B, Haase D, Siebert R, Ghadimi BM, Neumann C, Emmert S.

Arch Dermatol. 2008 Mar;144(3):361-4.PMID: 18347292 [PubMed - indexed for MEDLINE]Related articlesFree article

Nilotinib (Tasigna) for CML.

[No authors listed]

Med Lett Drugs Ther. 2008 Apr 7;50(1283):26-7. No abstract available. PMID: 18391899 [PubMed - indexed for MEDLINE]Related articles

Non-receptor tyrosine kinase inhibitors in lung cancer.

Hahn O, Salgia R.

Anticancer Agents Med Chem. 2007 Nov;7(6):633-42. Review.PMID: 18045058 [PubMed - indexed for MEDLINE]Related articles